Veuillez patienter, nous chargeons les données du graphique
Communauté AstraZeneca PLC
About AstraZeneca PLC
What is AstraZeneca PLC?
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 148,33 €, with a 24-hour trading volume of 448,29M €. The asset's market cap is 230,05B €, after moving -1.57% in the last day.
Tokenized AstraZeneca PLC is trading at 84,24 €, with a tokenized market cap of 47,69M € and a 24-hour trading volume of 708,17K €. The tokenized asset has moved 10.15% in the past 24 hours.